Buy Avanos Medical

Logo for stock AVNS (Avanos Medical)

Amount

£
GBP

Latest price

$11.58
(£1.00 = $1.348)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$538.269M

P/E ratio

-1.15

EPS

-$10.063

Beta

1.12

Dividend rate

N/A

Dividend yield

N/A

About

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Its segment includes Specialty Nutrition Systems and Pain Management and Recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which includes products such as MIC-KEY enteral feeding tubes and Corpak patient feeding solutions and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products used to treat chronic pain conditions.

CEO

Mr. David Pacitti

Employees

2,227

Sector

Health

Company HQ

ALPHARETTA, United States of America

Website

News

Logo for news article #0 (Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down)

Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down

AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.

Zacks Investment Research

August 06, 2025

Logo for news article #1 (Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript)

Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript

Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.

Seeking Alpha

August 05, 2025

Logo for news article #2 (Avanos Medical (AVNS) Q2 Revenue Up 2%)

Avanos Medical (AVNS) Q2 Revenue Up 2%

Avanos Medical (AVNS) Q2 Revenue Up 2%

The Motley Fool

August 05, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies is an Introducer Appointed Representative of Quint Group Limited and not a lender. Quint Group Limited is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 669450). Monevo Limited is an Appointed Representative of TransUnion International UK Limited. TransUnion is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 737740). Emma Technologies introduces customers first to Quint Group Limited, as a licensed credit broker, who then refers on to Monevo Limited.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.